CAMBRIDGE, Mass.--Ariad Pharmaceuticals has been granted its first foreign patents--in Europe and Japan. They cover novel genes that encode for proteins that bind to Ariad’s small-molecule drugs and control cellular activity through regulated gene transcription and protein secretion.